Hydrofluoric Acid Burns — Calcium Therapy

Key Points

• HF toxicity is caused by both corrosive hydrogen ions and deeply penetrating fluoride ions that bind calcium and magnesium.
• Pain can be delayed after low-concentration exposure, so a painless early examination does not exclude important injury.
• Begin decontamination immediately, then use calcium therapy to bind fluoride.
• Significant exposure requires continuous ECG monitoring and serial ionized calcium, magnesium, and potassium measurements.
• Persistent pain after topical calcium is a practical marker of ongoing local toxicity and should prompt escalation.
• Digital burns may require regional calcium techniques or surgical involvement because infiltration can increase tissue pressure.
• Malignant dysrhythmias and cardiovascular collapse are manifestations of systemic fluoride toxicity and require aggressive calcium and magnesium therapy.

Algorithm

1. Remove the patient and staff from contamination risk; remove clothing and jewelry.
2. Irrigate exposed skin immediately and thoroughly with water.
3. Apply 2.5 percent calcium gluconate gel repeatedly to dermal exposure while monitoring pain response.
4. Obtain continuous ECG monitoring and serial ionized calcium, magnesium, potassium, renal function, and acid-base studies for significant exposure.
5. Escalate persistent focal pain to toxicology-guided local infiltration or regional calcium treatment, especially for digital injuries.
6. Treat systemic hypocalcemia or hypomagnesemia with intravenous replacement and manage hyperkalemia and dysrhythmias aggressively.
7. Provide airway and pulmonary support for inhalation exposure and urgent ophthalmic irrigation and consultation for eye exposure.
8. Admit or transfer significant injuries to a burn-capable center with toxicology support.

Clinical Synopsis & Reasoning

Hydrofluoric acid is uniquely dangerous because fluoride ions penetrate tissue deeply and bind calcium and magnesium. A small skin lesion can therefore produce severe pain, progressive tissue necrosis, hypocalcemia, hypomagnesemia, hyperkalemia, ventricular dysrhythmias, and cardiovascular collapse. Injury severity depends on concentration, exposed surface area, duration of contact, and anatomic site. High-concentration exposures cause immediate pain and visible destruction, while lower-concentration solutions may produce delayed pain for hours, creating false reassurance.

Suspect HF in glass etching, semiconductor work, metal cleaning, rust removal, wheel cleaners, and other industrial products. Pain out of proportion to the early skin appearance is a classic clue. Finger and nail-bed exposures are particularly difficult because fluoride can penetrate deeply in a confined space. Inhalation can cause airway and pulmonary injury with systemic fluoride absorption, and ingestion is a life-threatening poisoning requiring immediate toxicology management.

The evaluation must extend beyond the skin. Obtain continuous cardiac monitoring and serial calcium, ionized calcium, magnesium, potassium, renal function, and acid-base measurements for significant exposures. ECG abnormalities can include QT prolongation and malignant ventricular dysrhythmias. A normal initial total calcium does not exclude evolving toxicity; ionized calcium is more directly relevant. Severe systemic poisoning may progress rapidly, so treatment should begin on clinical suspicion rather than waiting for every laboratory result.

Treatment Strategy & Disposition

Protect staff, remove contaminated clothing and jewelry, and immediately irrigate exposed skin with copious water after brushing off any dry material. Following irrigation, apply 2.5 percent calcium gluconate gel liberally to dermal burns and massage it into the affected area while wearing protective gloves. Continue or reapply until pain is substantially relieved. Persistent pain despite appropriate topical therapy suggests ongoing fluoride activity and is an indication for escalation with specialist guidance.

For focal dermal injuries that do not respond to topical calcium, local subcutaneous or intradermal calcium gluconate infiltration may be used by experienced clinicians. Digital injuries can require regional intravenous calcium techniques because simple infiltration risks excessive tissue pressure in a confined space. Inhalational injury may be treated with nebulized calcium gluconate in addition to oxygen and standard airway care. Ocular HF exposure requires immediate water or saline irrigation and urgent ophthalmology consultation; direct calcium instillation into the eye should follow specialist guidance rather than improvised treatment.

Systemic toxicity requires intravenous calcium and magnesium replacement guided by ionized levels, ECG, and clinical response. Hyperkalemia should be treated with standard emergency measures while correcting fluoride toxicity. Refractory dysrhythmias may require repeated calcium, magnesium, advanced resuscitation, and toxicology-directed interventions. Early consultation with a poison center, medical toxicologist, and burn center is recommended for significant exposure. Patients with large-area burns, concentrated solutions, delayed severe pain, inhalation or ingestion, ECG abnormalities, electrolyte disturbance, or digital involvement require monitored care and often admission.

Epidemiology / Risk Factors

• Occupational exposure occurs in glass, metal, electronics, semiconductor, and automotive industries.
• Consumer wheel cleaners and rust removers can contain HF or related fluoride compounds.
• Digital exposures are common because hands are frequently involved in handling contaminated products.
• Severe systemic toxicity can occur from relatively small body-surface exposures when the HF concentration is high.

Investigations

Therapy at a Glance

Pharmacology

Prognosis / Complications

• Small low-concentration exposures treated promptly usually recover without systemic toxicity.
• Delayed decontamination and delayed calcium therapy increase the risk of deep tissue necrosis and prolonged pain.
• Large or concentrated exposures can cause refractory electrolyte abnormalities, ventricular dysrhythmias, and death.
• Early normalization of pain, ECG, and ionized electrolytes is reassuring but does not replace an exposure-specific observation plan.

Patient Education / Counseling

• Explain that HF can continue damaging tissue after the surface looks clean and that delayed pain is possible.
• Patients discharged after minor exposure need explicit return precautions for recurrent pain, numbness, weakness, palpitations, dizziness, or worsening skin injury.
• Occupational exposures should trigger review of gloves, splash protection, calcium-gluconate availability, and emergency procedures.
• Advise workers never to handle HF without appropriate chemical-resistant personal protective equipment and immediate access to decontamination.

Notes

HF management should not be reduced to applying gel. The gel is an important local antidote, but systemic monitoring is essential when exposure concentration, surface area, route, symptoms, or anatomy creates a meaningful risk of fluoride absorption. Severe toxicity can become a cardiac emergency before the skin wound appears dramatic.

The CDC and ATSDR medical management guidance supports calcium gluconate as the central antidotal therapy after decontamination. Local protocols should specify gel preparation, infiltration technique, indications for regional therapy, and when to transfer to a burn center because improvised calcium procedures in the digits can cause harm.

References

1. CDC/ATSDR Hydrogen Fluoride Medical Management Guidelines — Link
2. CDC Hydrogen Fluoride Chemical Fact Sheet — Link
3. American Burn Association Guidelines for Burn Patient Referral — Link